Alerus Financial Na Eli Lilly & CO Transaction History

Alerus Financial Na

$1.3 Billion
Q3 2024

A detailed history of Alerus Financial Na transactions in Eli Lilly & CO stock. As of the latest transaction made, Alerus Financial Na holds 20,507 shares of LLY stock, worth $15.3 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

20,507

Previous 21,788 5.88%

Holding current value

$15.3 Million

Previous $19.7 Million 7.9%

% of portfolio

1.39%

Previous 1.53%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $989,111 - $1.23 Million	-1,281 Reduced 5.88%	20,507 $18.2 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $817,653 - $1.03 Million	-1,128 Reduced 4.92%	21,788 $19.7 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $544,824 - $728,897	-920 Reduced 3.86%	22,916 $17.8 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $3.28 Million - $3.87 Million	6,246 Added 35.51%	23,836 $13.9 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $2.11 Million - $2.91 Million	-4,862 Reduced 21.66%	17,590 $9.45 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $242,361 - $324,065	-691 Reduced 2.99%	22,452 $10.5 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $265,278 - $311,556	854 Added 3.83%	23,143 $7.95 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $689,724 - $803,667	2,145 Added 10.65%	22,289 $8.15 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.83 Million - $3.22 Million	9,538 Added 89.93%	20,144 $6.51 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $614,599 - $721,630	-2,205 Reduced 17.21%	10,606 $3.44 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $61,254 - $76,123	261 Added 2.08%	12,811 $3.67 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $840,489 - $1.04 Million	-3,738 Reduced 22.95%	12,550 $3.47 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $387,800 - $477,242	-1,750 Reduced 9.7%	16,288 $3.76 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $697,825 - $902,632	3,865 Added 27.27%	18,038 $4.14 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $1.63 Million - $2.11 Million	-9,902 Reduced 41.13%	14,173 $2.65 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $142,984 - $189,202	-1,096 Reduced 4.35%	24,075 $4.07 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $2.51 Million - $2.9 Million	17,153 Added 213.93%	25,171 $3.73 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $1.09 Million - $1.32 Million	8,018 New	8,018 $1.32 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alerus Financial Na, based on Form 13F filings with the SEC.

News

Stay updated on Alerus Financial Na with notifications on news.

Account

Alerus Financial Na Eli Lilly & CO Transaction History